Kizzmekia Corbett’s team was the first to demonstrate a vaccine that successfully stopped viral replication in both the lungs and nose.

Kizzmekia Corbett’s team was the first to demonstrate a vaccine that successfully stopped viral replication in both the lungs and nose.
After three months of studies, the vaccine her team developed is about to enter a phase I clinical trial, a crucial hurdle on the way to FDA approval.
Hundreds of Meyerhoff Scholars Program alumni gathered to celebrate the program’s 30th anniversary, and to thank Robert E. Meyerhoff for his bold vision.
“To whom much is given, much is required.” Meyerhoff scholars internalize this message, which is introduced during Summer Bridge and is almost as ubiquitous as “Focus, Focus, Focus,” and...
From its very first days, Earnestine Baker, Executive Director Emerita, has been an integral part of the Meyerhoff Scholars Program. UMBC Magazine sat down...
With their hearts in the work and their ears to the ground, the people behind some of UMBC’s longest-standing homegrown programs are solving big societal problems. But the work is never done.
Two Meyerhoff Scholars Program alumnae, Kavita Krishnaswamy, M13, '07, mathematics, and Tabassum Majid, M18, M.A. '18, aging studies, '10, interdisciplinary...
For Annica Wayman M6, ’99, mechanical engineering, this fall marks a homecoming wrapped up in a new beginning. After eight...
UMBC has named its inaugural LaMont Toliver Scholar — graduating senior chemical engineering major Adrian Davey ’18, a member of the 26th Meyerhoff Scholars cohort.
Becoming an academic superstar doesn’t happen overnight. It takes grit, character, and a community of true believers. Luckily for Naomi Mburu ’18 — UMBC’s very first Rhodes Scholar — she has all three.